$IRMD 8-K/A SEC Filings

Filed On	Filing
18 Aug 2026	8-K/A: Results of Operations and Financial Condition Orlando, Florida, July 31, 2026 – IRADIMED CORPORATION (the “Company” or “Iradimed”) (NASDAQ: IRMD) announced today its financial results for the three and six months ended June 30, 2026. The Company is a leader in developing innovative ...
03 Nov 2017	8-K/A: Entry into a Material Definitive Agreement

Comments